Interesting that Nexium (number 2 last year) has dropped completely out of the top 10. Insurance company muscle finally having some impact (forcing switches to comparable generics).
Here's data for the top 100 for the last few years:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.